专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US08755881B2 Pacing therapy adjustment based on ventriculo-atrial delay 有权
标题翻译：基于心房 - 心房延迟的起搏治疗调整
公开(公告)号：US08755881B2
公开(公告)日：2014-06-17
申请号：US12363439
申请日：2009-01-30
申请人： Daniel R. Kaiser , Nicholas D. Skadsberg , Steven R. Hornberger , Thomas J. Mullen
发明人： Daniel R. Kaiser , Nicholas D. Skadsberg , Steven R. Hornberger , Thomas J. Mullen
IPC分类号： A61N1/365 , A61N1/368
CPC分类号： A61N1/368 , A61N1/3622 , A61N1/3682
摘要： Techniques for adjusting pacing therapy based on ventriculo-atrial delay are described herein. These techniques may be used to control ventricular filling times during the delivery of pacing therapy. In some examples, a device or system delivers pre-excitation fusion pacing therapy to a ventricular chamber, determines a ventriculo-atrial delay interval for the ventricular chamber for at least one cardiac cycle, and adjusts the pacing therapy delivered by the implantable medical device to compensate for decreased ventricular filling time when the ventriculo-atrial delay interval is less than a threshold. In some examples, the device or system may adjust the pacing therapy by decreasing a pacing rate of the implantable medical device, increasing a pre-excitation interval for pacing of the ventricular chamber, and/or switching from a fusion pacing mode to a biventricular pacing mode.
摘要翻译：本文描述了基于心房 - 心房延迟来调节起搏治疗的技术。这些技术可用于控制起搏治疗期间的心室充盈时间。在一些示例中，装置或系统将预激发融合起搏治疗递送至心室，确定心室至少一个心动周期的心房 - 心房延迟间隔，并调整由可植入医疗装置递送的起搏疗法补偿当心室 - 心房延迟间隔小于阈值时心室充盈时间减少。在一些示例中，装置或系统可以通过降低可植入医疗装置的起搏速率，增加心室的起搏间隔和/或从融合起搏模式切换到双心室起搏来调节起搏治疗模式。

2. 发明申请

US20100198293A1 PACING THERAPY ADJUSTMENT BASED ON VENTRICULO-ATRIAL DELAY 有权
标题翻译：基于静脉血管延迟的PACING治疗调整
公开(公告)号：US20100198293A1
公开(公告)日：2010-08-05
申请号：US12363439
申请日：2009-01-30
申请人： Daniel R. Kaiser , Nicholas D. Skadsberg , Steven R. Hornberger , Thomas J. Mullen
发明人： Daniel R. Kaiser , Nicholas D. Skadsberg , Steven R. Hornberger , Thomas J. Mullen
IPC分类号： A61N1/365
CPC分类号： A61N1/368 , A61N1/3622 , A61N1/3682
摘要： Techniques for adjusting pacing therapy based on ventriculo-atrial delay are described herein. These techniques may be used to control ventricular filling times during the delivery of pacing therapy. In some examples, a device or system delivers pre-excitation fusion pacing therapy to a ventricular chamber, determines a ventriculo-atrial delay interval for the ventricular chamber for at least one cardiac cycle, and adjusts the pacing therapy delivered by the implantable medical device to compensate for decreased ventricular filling time when the ventriculo-atrial delay interval is less than a threshold. In some examples, the device or system may adjust the pacing therapy by decreasing a pacing rate of the implantable medical device, increasing a pre-excitation interval for pacing of the ventricular chamber, and/or switching from a fusion pacing mode to a biventricular pacing mode.
摘要翻译：本文描述了基于心房 - 心房延迟来调节起搏治疗的技术。这些技术可用于控制起搏治疗期间的心室充盈时间。在一些示例中，装置或系统将预激发融合起搏治疗递送至心室，确定心室至少一个心动周期的心房 - 心房延迟间隔，并调整由可植入医疗装置递送的起搏疗法补偿当心室 - 心房延迟间隔小于阈值时心室充盈时间减少。在一些示例中，装置或系统可以通过降低可植入医疗装置的起搏速率，增加心室的起搏间隔和/或从融合起搏模式切换到双心室起搏来调节起搏治疗模式。

3. 发明授权

US07599740B2 Ventricular event filtering for an implantable medical device 有权
标题翻译：可植入医疗器械的心室事件过滤
公开(公告)号：US07599740B2
公开(公告)日：2009-10-06
申请号：US11748659
申请日：2007-05-15
申请人： Robert A. Betzold , David A. Casavant , Paul A. Belk , Thomas J. Mullen , John C. Stroebel , Steven R. Hornberger , Todd J. Sheldon , Douglas A. Peterson
发明人： Robert A. Betzold , David A. Casavant , Paul A. Belk , Thomas J. Mullen , John C. Stroebel , Steven R. Hornberger , Todd J. Sheldon , Douglas A. Peterson
IPC分类号： A61N1/362
CPC分类号： A61N1/368 , A61N1/3688 , A61N1/3702
摘要： Pacing parameters are provided to address cross talk and intrinsic ventricular events occurring within a predefined blanking period following an atrial event. The parameters are used in conjunction with protocol for minimizing or reducing ventricular pacing, wherein ignoring intrinsic ventricular events during the blanking period might otherwise affect the performance of the protocol.
摘要翻译：提供起搏参数以解决心房事件发生后的预定义消隐期间发生的串扰和内在心室事件。这些参数与协议一起使用以最小化或减少心室起搏，其中在消隐期间忽略内部心室事件可能会影响该方案的性能。

4. 发明授权

US07245966B2 Ventricular event filtering for an implantable medical device 有权
标题翻译：可植入医疗器械的心室事件过滤
公开(公告)号：US07245966B2
公开(公告)日：2007-07-17
申请号：US10850666
申请日：2004-05-21
申请人： Robert A. Betzold , David A Casavant , Paul A. Belk , Thomas J. Mullen , John C. Stroebel , Steven R. Hornberger , Todd J. Sheldon , Douglas A. Peterson
发明人： Robert A. Betzold , David A Casavant , Paul A. Belk , Thomas J. Mullen , John C. Stroebel , Steven R. Hornberger , Todd J. Sheldon , Douglas A. Peterson
IPC分类号： A61N1/00
CPC分类号： A61N1/368 , A61N1/3688 , A61N1/3702
摘要： Pacing parameters are provided to address cross talk and intrinsic ventricular events occurring within a predefined blanking period following an atrial event. The parameters are used in conjunction with protocol for minimizing or reducing ventricular pacing, wherein ignoring intrinsic ventricular events during the blanking period might otherwise affect the performance of the protocol.
摘要翻译：提供起搏参数以解决心房事件发生后的预定义消隐期间发生的串扰和内在心室事件。这些参数与协议一起使用以最小化或减少心室起搏，其中在消隐期间忽略内部心室事件可能会影响该方案的性能。

5. 发明授权

US08060202B2 Ventricular event filtering for an implantable medical device 有权
标题翻译：可植入医疗器械的心室事件过滤
公开(公告)号：US08060202B2
公开(公告)日：2011-11-15
申请号：US12574585
申请日：2009-10-06
申请人： Robert A. Betzold , David A. Casavant , Paul A. Belk , Thomas J. Mullen , John C. Stroebel , Steven R. Hornberger , Todd J. Sheldon , Douglas A. Peterson
发明人： Robert A. Betzold , David A. Casavant , Paul A. Belk , Thomas J. Mullen , John C. Stroebel , Steven R. Hornberger , Todd J. Sheldon , Douglas A. Peterson
IPC分类号： A61N1/18
CPC分类号： A61N1/368 , A61N1/3688 , A61N1/3702
摘要： Pacing parameters are provided to address cross talk and intrinsic ventricular events occurring within a predefined blanking period following an atrial event. The parameters are used in conjunction with protocol for minimizing or reducing ventricular pacing, wherein ignoring intrinsic ventricular events during the blanking period might otherwise affect the performance of the protocol.
摘要翻译：提供起搏参数以解决心房事件发生后的预定义消隐期间发生的串扰和内在心室事件。这些参数与协议一起使用以最小化或减少心室起搏，其中在消隐期间忽略内部心室事件可能会影响该方案的性能。

6. 发明申请

US20100087882A1 VENTRICULAR EVENT FILTERING FOR AN IMPLANTABLE MEDICAL DEVICE 有权
标题翻译：可植入医疗器械的静脉内过滤
公开(公告)号：US20100087882A1
公开(公告)日：2010-04-08
申请号：US12574585
申请日：2009-10-06
申请人： Robert A. Betzold , David A. Casavant , Paul A. Belk , Thomas J. Mullen , John C. Stroebel , Steven R. Hornberger , Todd J. Sheldon , Douglas A. Peterson
发明人： Robert A. Betzold , David A. Casavant , Paul A. Belk , Thomas J. Mullen , John C. Stroebel , Steven R. Hornberger , Todd J. Sheldon , Douglas A. Peterson
IPC分类号： A61N1/368 , A61N1/39
CPC分类号： A61N1/368 , A61N1/3688 , A61N1/3702
摘要： Pacing parameters are provided to address cross talk and intrinsic ventricular events occurring within a predefined blanking period following an atrial event. The parameters are used in conjunction with protocol for minimizing or reducing ventricular pacing, wherein ignoring intrinsic ventricular events during the blanking period might otherwise affect the performance of the protocol.
摘要翻译：提供起搏参数以解决心房事件发生后的预定义消隐期间发生的串扰和内在心室事件。这些参数与协议一起使用以最小化或减少心室起搏，其中在消隐期间忽略内部心室事件可能会影响该方案的性能。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式